Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zocor and Avonex in Relapsing Remitting Multiple Sclerosis
NCT00242268Phase 3Unknown
- Sponsor
- Alabama Neurology Associates
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simvastatin in relapsing-remitting multiple sclerosis (RRMS), sponsored by Alabama Neurology Associates. Status: unknown.
02
Drugs
simvastatin
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00242268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242268.